对于肺部健康的纳米载体:使用基于黄类的纳米营养素改善炎症和细胞衰老
Parteek Prasher1, Mousmee Sharma2, Rabab Fatima3
1Department of Chemistry, UPES, Dehradun, Uttarakhand, India.
Immunopharmacology and immunotoxicology
|March 5, 2026
概括
类纳米载体通过减少肺炎和改善药物输送来有效治疗慢性呼吸道疾病. 这些先进的系统提高了生物可用性,并提供持续释放,以获得更好的肺部健康结果.
科学领域:
- 纳米医学是一种纳米医学.
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 慢性呼吸道疾病 (CRDs) 影响全球超过5.45亿人,COPD导致显著的死亡率.
- 黄类药物表现出抗炎功能,但具有较差的溶解性和生物可用性.
- 纳米载体系统提供了改善的肺部输送,可溶性和黄素的向释放.
研究的目的:
- 审查含有黄胺的纳米载体在治疗CRD方面的潜力.
- 探索它们在调节炎症和细胞衰老中的作用.
- 评估它们的持续释放和对肺部健康的生物相容性.
主要方法:
- 在炎症途径 (NF-κB,Nrf2/Keap1) 和酶 (COX,5-LOX,iNOS) 中对黄类机制的全面分析.
- 数据来源于PubMed,ScienceDirect,Web of Science,TRIP和Springer. 这些数据均来源于其他网站.
- 使用世界植物在线,世卫组织和ChemSpider进行分类学,流行病学和化学数据的验证.
主要成果:
- 类纳米载体表现出显著的抗炎和抗氧化作用.
- PLGA系统将TNF-α和IL-6降低了高达80%;脂质载体提高了生物可用性2-5倍.
- 脂质体改善了细胞活力 (40-50%) 并减少了氧化应激 (>60%);可吸入配方显示出优异的肺度和保留.
结论:
- 含有黄胺的纳米载体,特别是脂质体,在CRD中增强了肺向,生物可用性和疗效.
- 这些纳米药物抑制炎症和细胞衰老,为肺部健康提供了一个有希望的策略.
- 对纳米载体系统的进一步研究可以促进慢性呼吸道疾病的治疗.
相关概念视频
02:59Cancer Prevention
8.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
8.5K
01:37Mitochondria
21.1K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.1K
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
64
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
64